Pharma Focus Asia
Eppendorf Bioprocess Solutions

Rentschler Biopharma Plans to Open New Manufacturing Center in Boston


Rentschler Biopharma plans to open new manufacturing site that will be an extension to the existing site in Milford, MA site.


The new state-of-the-art facility includes four new 2,000 L single-use bioreactors and also adds cleanroom space for manufacturing consisting of 22,000 square feet.

The addition of new production site to the existing site is made to further increase the clinical and commercial supply of biopharmaceuticals and expand cGMP manufacturing capacity.

The new facility will be equipped with highly automated production lines consisting of industry 4.0 solutions. Moreover, the site will be designed with advanced technologies, innovative digital and analytical services.

With the increasing manufacturing footprint, the facility will expand its quality control (QC), development, and warehousing capabilities. The new production site doubles the commercial cGMP manufacturing capacity. It is expected that the new site will start its operations in late 2023.


NameRentschler Biopharma
TypeNew Construction
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACPHI Korea 2023Bora Pharmaceutical - A robust approach to analytical testing is essentialSelangor International Expo MEDIC 2023TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile AppCPHI & PMEC China 20233rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023Pharma Regulatory Conclave 202320th Anniversary Hospitalog Asia 2023
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology